Company Overview - Arthur J. Gallagher & Co. (AJG) has a market cap of $57.9 billion and operates as a global insurance and reinsurance brokerage firm, providing risk management, consulting, and claims services to businesses and individuals worldwide [1] - The company serves a diverse clientele, including commercial, industrial, public, religious, and nonprofit organizations, through a vast global network of brokers and consultants [2] Stock Performance - AJG shares have declined 35.9% from their 52-week high of $351.23, with an 8.2% decrease over the past three months, underperforming the Nasdaq Composite's 4% dip during the same period [3] - Year-to-date, AJG stock is down nearly 13%, compared to a 3.1% decline in the Nasdaq Composite, and has dropped 34.1% over the past 52 weeks, while the Nasdaq Composite has increased by 22.7% [3] Technical Indicators - AJG stock has been trading below its 50-day and 200-day moving averages since early June 2025 [4] Financial Performance - Following its Q4 2025 results, AJG shares rose 1.4% after reporting 5% organic growth in brokerage, 38% growth in reported brokerage revenue, and 30% growth in adjusted EBITDAC, marking 23 consecutive quarters of double-digit EBITDAC growth [5] - Management reaffirmed a 2026 brokerage organic growth guidance of around 5.5% and projected $160 million in annualized integration synergies by the end of 2026, with a longer-term target of $260 million to $280 million by early 2028 [5] Competitive Position - AJG has shown a more pronounced decline compared to its rival, Marsh & McLennan Companies, Inc. (MMC), which has fallen 1.5% year-to-date and 13.6% over the past 52 weeks [6] - Despite the stock's weak performance, analysts maintain a moderately optimistic outlook, with a consensus rating of "Moderate Buy" from 23 analysts and a mean price target of $283.74, indicating a potential premium of nearly 26% to current levels [6]
Is Arthur J. Gallagher Stock Underperforming the Nasdaq?